Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone in Alcohol Use Disorder and Major Depressive Disorder
NCT07734701Phase 2Not yet recruiting
- Start
- Oct 2026
- Primary completion
- Mar 2031
- Countries
- 1
01
Overview
A Phase 2 trial of pregnenolone in alcohol use disorder (AUD), major depressive disorder (MDD). Planned start Oct 2026; status: not yet recruiting.
02
Drugs
pregnenolone
03
Conditions
alcohol use disorder (AUD)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07734701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07734701.